CVNA insider plans sale of 12,750 shares

A holder of CVNA common stock has filed a notice to sell 12,750 shares of common stock through Morgan Stanley Smith Barney on or about 02/02/2026 on the NYSE.

Rhea-AI Filing Summary

A holder of CVNA common stock has filed a notice to sell 12,750 shares of common stock through Morgan Stanley Smith Barney on or about 02/02/2026 on the NYSE. The filing lists an aggregate market value of $5,114,152.50 for this planned sale, compared with 141,423,193 shares of common stock outstanding.

The shares to be sold were acquired on 02/02/2026 by exercising stock options for 12,750 shares, paid in cash. The notice also discloses prior Rule 10b5-1 sales by Mark Jenkins over the past three months, each for 12,750 common shares, with disclosed gross proceeds of $5,138,510.80, $4,794,934.50, and $4,122,756.80 on the stated dates.

FAQ

What does the latest Form 144 filing for CVNA disclose?

The Form 144 shows a planned sale of 12,750 CVNA common shares on or about 02/02/2026. The filing reports an aggregate market value of $5,114,152.50 for this sale and notes the shares were acquired via stock option exercise.

How many CVNA shares are covered by the new planned sale?

The notice covers a planned sale of 12,750 CVNA common shares. These shares were acquired on 02/02/2026 through the exercise of stock options and are scheduled to be sold through Morgan Stanley Smith Barney on the NYSE.

What prior CVNA stock sales are reported in this Form 144?

The filing lists three prior Rule 10b5-1 sales of 12,750 CVNA shares each, on 11/03/2025, 12/01/2025, and 01/02/2026. Reported gross proceeds were $4,122,756.80, $4,794,934.50, and $5,138,510.80, respectively.

How were the CVNA shares in the planned sale acquired?

The 12,750 CVNA shares in the planned sale were acquired on 02/02/2026 through an exercise of stock options. The filing states that the exercise was paid in cash, and the same number of shares is now intended to be sold.

What is the reported market value and outstanding CVNA shares in this filing?

For the planned sale, the filing reports an aggregate market value of $5,114,152.50. It also discloses that 141,423,193 CVNA common shares were outstanding, providing context for the relative size of the planned transaction.

Which broker is handling the planned CVNA stock sale under this Form 144?

The planned sale of 12,750 CVNA common shares will be handled by Morgan Stanley Smith Barney LLC Executive Financial Services. The shares are indicated to be sold on the NYSE, according to the broker and exchange information disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/02/2026 - 04:34 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001700540
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CARVANA CO
SEC File Number	001-38073
Address of Issuer	300 E. Rio Salado Parkway Tempe ARIZONA 85281
Phone	6029229866
Name of Person for Whose Account the Securities are To Be Sold	MARK JENKINS
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	12750	5114152.50	141423193	02/02/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/02/2026	Exercise of Stock Options	Issuer			12750	02/02/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for MARK JENKINS 300 E. Rio Salado Parkway Tempe AZ 85281	Common	01/02/2026	12750	5138510.80
10b5-1 Sales for MARK JENKINS 300 E. Rio Salado Parkway Tempe AZ 85281	Common	12/01/2025	12750	4794934.50
10b5-1 Sales for MARK JENKINS 300 E. Rio Salado Parkway Tempe AZ 85281	Common	11/03/2025	12750	4122756.80

144: Remarks and Signature

Remarks
Date of Notice	02/02/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/05/2024
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Mark Jenkins
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)